Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: Results of a phase 1/2 study

Paul G. Richardson, Asher A. Chanan-Khan, Sagar Lonial, Amrita Y. Krishnan, Michael P. Carroll, Melissa Alsina, Maher Albitar, David Berman, Marianne Messina, Kenneth C. Anderson

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: Results of a phase 1/2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences